Tempus and Eric Lefkofsky Help Cancer Patients Fight the Hardest Fight

When life hands you lemons, you have to either make lemonade or throw them away. For Eric Lefkofsky, he was handed lemons personally when his wife was diagnosed with breast cancer. Instead of sitting idly by, he decided to come up with a plan that would help his wife as well as help her doctors. That is where Tempus fell into place.

The goal of Tempus is to help patients and doctors find a way to share crucial information that is then stored and collected for cancer patients. In most cases, the information is submitted in form of a doctor’s note or a progress note. The notes are generally submitted to help capture and analyze data collected from patients. Tempus created a method to use the natural language from a doctor to enter information into a patient’s medical charts. This data is structured into data that is usable and helps to advance the care for cancer patients.

For cancer patients, the human genome sequencing is vital in the treatment plan for patients who have cancer. When the first case started in 2003, the cost for the genome sequencing was close to a 100 million dollars whereas today, the cost is close to $5,000. The plunge has been thanks to companies much like Tempus who are aiding to drive the prices down on tests and procedures and learn more about Eric.

Eric Lefkofsky was raised in Michigan and attended school in Michigan. He started off at the bottom just like anyone else. He started out selling carpet at Michigan University and once law school was over and he graduated, he and his friend borrowed some money from a few relatives in order to purchase an apparel company in Madison, Wisconsin. Then in 1999, Eric started an early internet business with his friend which specialized in various promotional products.

Once the internet business went under, he co-founded InnerWorkings. This business started in 2001 and provided a number of print documents for services and companies. In 2006, Eric went public on the stock market with the business and he sat on the board of InnerWorkings until October 2012 and read full article.